What happens to the heart in chronic kidney disease?

Area of Science:

• Nephrology
• Cardiology
• Internal Medicine

Background:

• Cardiovascular disease (CVD) is highly prevalent in chronic kidney disease (CKD) patients.
• CKD patients exhibit exaggerated risk for sudden cardiac death, especially in end-stage renal disease (ESRD), with a ~20x higher risk than the general population.
• While atherosclerosis is accelerated in CKD, it doesn't fully explain the excess cardiovascular risk.

Purpose of the Study:

• To investigate the early structural and functional cardiac alterations in CKD patients.
• To understand the contribution of these cardiac changes to adverse cardiovascular outcomes.
• To identify potential targets for mitigating cardiovascular risk in CKD.

Main Methods:

• This study synthesizes current research on cardiovascular complications in CKD.
• It reviews evidence on traditional and novel vascular risk factors in CKD.
• Analysis focuses on cardiac remodeling, hypertrophy, and their implications.

Main Results:

• Cardiac structure and function begin to change early in CKD, irrespective of other risk factors.
• Cardiac remodeling and hypertrophy are identified as key contributors to heart failure, arrhythmia, and myocardial ischemia in CKD.
• The findings highlight that factors beyond accelerated atherosclerosis play a crucial role in CVD risk.

Conclusions:

• Early cardiac remodeling and hypertrophy in CKD significantly increase the risk of heart failure, arrhythmia, and ischemic events.
• Further research is essential to develop strategies for reducing cardiovascular risk in CKD patients.
• Addressing structural and functional heart disease is critical for improving outcomes in CKD.